(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.31%) $83.83
(-3.30%) $1.584
(0.12%) $2 345.40
(0.30%) $27.44
(1.06%) $930.30
(0.10%) $0.933
(0.11%) $10.96
(0.06%) $0.800
(0.02%) $92.18
Live Chart Being Loaded With Signals
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases...
Stats | |
---|---|
Today's Volume | 351 642 |
Average Volume | 538 392 |
Market Cap | 16.71M |
EPS | $0 ( 2024-03-27 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.632 |
ATR14 | $0.0250 (5.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-11 | Angelico Paul | Buy | 29 333 | Common Stock |
2023-03-15 | Angelico Paul | Buy | 7 885 | Common Stock |
2023-03-15 | Angelico Paul | Sell | 2 843 | Common Stock |
2023-03-11 | Angelico Paul | Sell | 10 575 | Common Stock |
2023-03-11 | Angelico Paul | Sell | 29 333 | Restricted stock units |
INSIDER POWER |
---|
-90.28 |
Last 100 transactions |
Buy: 781 277 | Sell: 10 790 554 |
Volume Correlation
Chembio Diagnostics Inc Correlation
10 Most Positive Correlations | |
---|---|
EWCZ | 0.948 |
FTDR | 0.94 |
NPCE | 0.938 |
HEWG | 0.937 |
DXGE | 0.932 |
ULTA | 0.931 |
WBD | 0.925 |
GLBE | 0.916 |
ROBT | 0.916 |
NRC | 0.912 |
10 Most Negative Correlations | |
---|---|
ADXN | -0.922 |
MHUA | -0.913 |
AHPI | -0.898 |
BAFN | -0.898 |
SBNY | -0.89 |
ESPR | -0.889 |
RAIL | -0.888 |
KZR | -0.886 |
IGMS | -0.884 |
LOCO | -0.883 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Chembio Diagnostics Inc Correlation - Currency/Commodity
Chembio Diagnostics Inc Financials
Annual | 2022 |
Revenue: | $48.34M |
Gross Profit: | $9.76M (20.19 %) |
EPS: | $-0.960 |
Q4 | 2022 |
Revenue: | $9.16M |
Gross Profit: | $3.55M (38.78 %) |
EPS: | $-0.0352 |
Q3 | 2022 |
Revenue: | $11.20M |
Gross Profit: | $1.54M (13.76 %) |
EPS: | $-0.260 |
Q2 | 2022 |
Revenue: | $9.16M |
Gross Profit: | $1.07M (11.73 %) |
EPS: | $-0.230 |
Financial Reports:
No articles found.
Chembio Diagnostics Inc
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators